Angiogenesis inhibitors overcome tumor induced endothelial cell anergy

International Journal of Cancer

Volumn 80, Issue 2, 1999, Pages 315-319

  Griffioen, Arjan W ^a   Damen, Cora A ^b   Mayo, Kevin H ^c   Barendsz Janson, Annemarie F ^a   Martinotti, Stefano ^d   Blijham, Geert H ^b   Groenewegen, Gerard ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; CLONAL ANERGY; DOWN REGULATION; ENDOTHELIUM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; TUMOR;

ANIMALS; CATTLE; CELL ADHESION; CLONAL ANERGY; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; NEOVASCULARIZATION, PATHOLOGIC; PLATELET FACTOR 4;

EID: 0033579869     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990118)80:2<315::AID-IJC23>3.0.CO;2-L     Document Type: Article

References (23)

1. BARENDSZ-JANSON, A.F., GRIFFIOEN, A.W., MULLER, A.D., VAN DAM-MIERAS, M.C.E. and HILLEN, H.F.P., In vitro tumor angiogenesis assays: plasminogen lysine binding site 1 (LBS-1) inhibits in vitro tumor induced angiogenesis. J. vasc. Res., 35, 109-114 (1998).
2. BEVILACQUA, M.P., Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol., 11, 767-804 (1993).
3. BUDSON, A.E., KO, L., BRASEL, C. and BISCHOFF, J., The angiogenesis inhibitor AGM-1470 selectively increases E-selectin. Biochem. biophys. Res. Comm., 225, 141-145 (1996).
4. CILENTI, L., TONIATO, E., RUGGIERO, P., FUSCO, C., FARINA, A.R., TIBERIO, A., HAYDAY, A.C., GULINO, A., FRATI, L. and MARTINOTTI, S. Transcriptional modulation of the human intercellular adhesion molecule gene 1 (ICAM-1) by retinoic acid in melanoma cells. Exp. Cell Res., 218, 263-270 (1995).
5. D'AMATO, R.J., LOUGHNAN, M.S., FLYNN, E. and FOLKMAN, J., Thalidomide is an inhibitor of angiogenesis. Proc. nat. Acad. Sci. (Wash.), 91, 4082-4085 (1994).
6. DAMERON, K.M., VOLPERT, O.V., TAINSKY, M.A. and BOUCK, N., Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 265, 1582-1584 (1994).
7. FOLKMAN, J., What is the evidence that tumors are angiogenesis dependent? J. nat. Cancer. Inst., 82, 4-6 (1990).
8. FOLKMAN, J. and SHING, Y., Angiogenesis. J. biol. Chem., 267, 10931-10934 (1992).
9. GRIFFIOEN, A.W., DAMEN, C.A., BLIJHAM, G.H. and GROENEWEGEN, G., Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor associated endothelium. Blood, 88, 667-673 (1996a).
10. GRIFFIOEN, A.W., DAMEN, C.A., MARTINOTTI, S., BLUHAM, G.H. and GROENEWEGEN, G., Endothelial ICAM-1 expression is suppressed in human malignancies; role of angiogenic factors. Cancer Res., 56, 1111-1117 (1996b).
11. GROENEWEGEN, G., DE LEU, M., JEUNHOMME, G.M.A.A. and BUURMAN, W.A., Supernatants of human leukocytes contain mediators, different from interferon-gamma, which induces expression of MHC class II antigens. J. exp. Med., 164, 131-143 (1986).
12. GUPTA, S.K., HASSEL, T. and SINGH, J.P., A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc. nat. Acad. Sci. (Wash.), 92, 7799-7803 (1995).
13. INGBER, D., FUJITA, T., KISHIMOTO, S., SUDO, K., KANAMARU, T., BREM, H. and FOLKMAN, J., Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (Lond.), 348, 555-557 (1990).
14. +) T-lymphocyte. Cancer. Res., 54, 4729-4733 (1994).
15. LUSTER, A.D., GREENBERG, S.M. and LEDER, P., The IP-10 chemokine binds to a specific cell surface heparin sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. exp. Med., 182, 219-231 (1995).
16. MELDER, R.J., KOENIG, G.C., WITWER, B.P., SAFABAKHSH, N., MUNN, L.L. and JAIN, R.K., During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med., 2, 992-997 (1996).
17. O'REILLY, M.S., BOEHM, T., SHING, Y., FUKAI, N., VASIOS, G., LANE, W.S., FLYNN, E., BIRKHEAD, J.R., OLSEN, B.R. and FOLKMAN, J., Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277-285 (1997).
18. O'REILLY, M.S., HOLMGREN, L., SHING, Y., CHEN, C., ROSENTHAL, R.A., MOSES, M., LANE, W.S., CAO, Y., SAGE, E.H. and FOLKMAN, J., Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79, 315-328 (1994).
19. PIALI, L., FICHTEL, A., TERPE, H.J., IMHOF, B.A. and GISLER, R.H., Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J. exp. Med., 181, 811-816 (1995).
20. SPRINGER, T.A., Traffic signals for lymphocyte recirculation and leukocyte emigration - the multistep paradigm. Cell, 76, 301-314 (1994).
21. TARABOLETTI, G., GAROFALO, A., BELOTTI, D., DRUDIS, T., BORSOTTI, P., SCANZIANI, E., BROWN, P.D. and GIAVAZZI, R., Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J. nat. Cancer Inst., 87, 293-298 (1995).
22. WATSON, S.A., MORRIS, T.M., ROBINSON, G., CRIMMIN, M.J., BROWN, P.D. and HARDCASTLE, J.D., Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res., 55, 3629-3633 (1995).
23. YANG, Y., MAYO, K.H., DALY, T.J., BARRY, J.K. and LA ROSA, G.J., Subunit association and structural analysis of platelet basic protein and related proteins investigated by 1H NMR spectroscopy and circular dichroism. J. Biol. Chem., 269, 20110-20118 (1994).